Skip to main content
SpringerLink
Log in

Role of Intervention and Surgery

  • Chapter
  • First Online:
Book cover Heart Failure in Adult Congenital Heart Disease

Part of the book series: Congenital Heart Disease in Adolescents and Adults ((CHDAA))

  • 654 Accesses

Abstract

Heart failure in adult patients with congenital heart disease (CHD) is often the result of long-standing abnormal workload to the subpulmonary and/or systemic ventricle leading to ventricular dysfunction. Interventional catheter procedures and surgery play a central role in the treatment of heart failure in this patient population by attempting to normalise the working conditions of the heart by reducing ventricular pressure or volume overload. When performed in a timely manner, intervention can prevent irreversible ventricular damage. This chapter will give an overview on commonly performed invasive procedures that aim to protect or improve ventricular function and cardiac output. New interventional therapeutic options such as creation of an interatrial communication are also discussed. Catheter-based interventions and surgery are complementary to each other and to medical therapies, and all three are part of a comprehensive therapeutic approach to heart failure treatment in adults with CHD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kotowycz MA, Therrien J, Ionescu-Ittu R, Owens CG, Pilote L, Martucci G, Tchervenkov C, Marelli AJ. Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc Interv. 2013;6:497–503.

    Article  PubMed  Google Scholar 

  2. Gatzoulis MA, Hechter S, Webb GD, Williams WG. Surgery for partial atrioventricular septal defect in the adult. Ann Thorac Surg. 1999;67:504–10.

    Article  CAS  PubMed  Google Scholar 

  3. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003;89:199–204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Investigators A. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836–44.

    Article  Google Scholar 

  5. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg. 2009;137:1334–41.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv. 2004;63:496–502.

    Article  PubMed  Google Scholar 

  7. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970;32:820–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Nyboe C, Karunanithi Z, Nielsen-Kudsk JE, Hjortdal VE. Long-term mortality in patients with atrial septal defect: a nationwide cohort-study. Eur Heart J. 2017. https://doi.org/10.1093/eurheartj/ehx687.

  9. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med. 1990;323:1645–50.

    Article  CAS  PubMed  Google Scholar 

  10. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340:839–46.

    Article  CAS  PubMed  Google Scholar 

  11. Diller G-P, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828–35.

    Article  PubMed  Google Scholar 

  12. Helber U, Baumann R, Seboldt H, Reinhard U, Hoffmeister HM. Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol. 1997;29:1345–50.

    Article  CAS  PubMed  Google Scholar 

  13. Giardini A, Donti A, Formigari R, Specchia S, Prandstraller D, Bronzetti G, Bonvicini M, Picchio FM. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol. 2004;43:1886–91.

    Article  PubMed  Google Scholar 

  14. Veldtman GR, Razack V, Siu S, El-Hajj H, Walker F, Webb GD, Benson LN, McLaughlin PR. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol. 2001;37:2108–13.

    Article  CAS  PubMed  Google Scholar 

  15. Attenhofer Jost CH, Oechslin E, Seifert B, Maly F, Fatio R, Turina J, Jenni R. Remodelling after surgical repair of atrial septal defects within the oval fossa. Cardiol Young. 2002;12:506–12.

    Article  PubMed  Google Scholar 

  16. Uebing A, Fischer G, Bethge M, Scheewe J, Schmiel F, Stieh J, Brossmann J, Kramer HH. Influence of the pulmonary annulus diameter on pulmonary regurgitation and right ventricular pressure load after repair of tetralogy of Fallot. Heart. 2002;88:510–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–7.

    Article  CAS  PubMed  Google Scholar 

  18. Eyskens B, Reybrouck T, Bogaert J, Dymarkowsky S, Daenen W, Dumoulin M, Gewillig M. Homograft insertion for pulmonary regurgitation after repair of tetralogy of fallot improves cardiorespiratory exercise performance. Am J Cardiol. 2000;85:221–5.

    Article  CAS  PubMed  Google Scholar 

  19. Frigiola A, Redington AN, Cullen S, Vogel M. Pulmonary regurgitation is an important determinant of right ventricular contractile dysfunction in patients with surgically repaired tetralogy of Fallot. Circulation. 2004;110:II153–7.

    Article  CAS  PubMed  Google Scholar 

  20. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13:9.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gaynor SL, Maniar HS, Bloch JB, Steendijk P, Moon MR. Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation. 2005;112:I212–8.

    PubMed  Google Scholar 

  22. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–82.

    Article  PubMed  Google Scholar 

  23. Uebing A, Fischer G, Schlangen J, Apitz C, Steendijk P, Kramer H-H. Can we use the end systolic volume index to monitor intrinsic right ventricular function after repair of tetralogy of Fallot? Int J Cardiol. 2011;147:52–7.

    Article  PubMed  Google Scholar 

  24. Heng EL, Gatzoulis MA, Uebing A, Sethia B, Uemura H, Smith GC, Diller G-P, McCarthy KP, Ho SY, Li W, Wright P, Spadotto V, Kilner PJ, Oldershaw P, Pennell DJ, Shore DF, Babu-Narayan SV. Immediate and midterm cardiac remodeling after surgical pulmonary valve replacement in adults with repaired tetralogy of Fallot: a prospective cardiovascular magnetic resonance and clinical study. Circulation. 2017;136:1703–13.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Baumgartner H, Bonhoeffer P, NMS DG, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, BJM M, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–57.

    Article  Google Scholar 

  26. Cheung EW-Y, Wong WH-S, Cheung Y-F. Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of Fallot. Am J Cardiol. 2010;106:552–7.

    Article  PubMed  Google Scholar 

  27. Babu-Narayan SV, Diller G-P, Gheta RR, Bastin AJ, Karonis T, Li W, Pennell DJ, Uemura H, Sethia B, Gatzoulis MA, Shore DF. Clinical outcomes of surgical pulmonary valve replacement after repair of tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing. Circulation. 2014;129:18–27.

    Article  PubMed  Google Scholar 

  28. Ferraz Cavalcanti PE, Sá MPBO, Santos CA, Esmeraldo IM, De Escobar RR, De Menezes AM, De Azevedo OM, De Vasconcelos Silva FP, RFDA L, RDC L. Pulmonary valve replacement after operative repair of Tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013;62:2227–43.

    Article  PubMed  Google Scholar 

  29. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le BJ, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.

    Article  CAS  PubMed  Google Scholar 

  30. Ansari MM, Cardoso R, Garcia D, Sandhu S, Horlick E, Brinster D, Martucci G, Piazza N. Percutaneous pulmonary valve implantation: present status and evolving future. J Am Coll Cardiol. 2015;66:2246–55.

    Article  PubMed  Google Scholar 

  31. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, Cooper J, Muthurangu V, Hegde SR, Razavi RS, Pellerin D, Deanfield J, Bonhoeffer P. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005;112:1189–97.

    Article  PubMed  Google Scholar 

  32. Cheatham JP, Hellenbrand WE, Zahn EM, Jones TK, Berman DP, Vincent JA, McElhinney DB. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131:1960–70.

    Article  PubMed  Google Scholar 

  33. Lurz P, Giardini A, Taylor AM, Nordmeyer J, Muthurangu V, Odendaal D, Mist B, Khambadkone S, Schievano S, Bonhoeffer P, Derrick G. Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity. Am J Cardiol. 2010;105:721–6.

    Article  PubMed  Google Scholar 

  34. Lurz P, Riede FT, Taylor AM, Wagner R, Nordmeyer J, Khambadkone S, Kinzel P, Derrick G, Schuler G, Bonhoeffer P, Giardini A, Daehnert I. Impact of percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction on exercise recovery kinetics. Int J Cardiol. 2014;177:276–80.

    Article  PubMed  Google Scholar 

  35. Nordmeyer J, Lurz P, Khambadkone S, Schievano S, Jones A, McElhinney DB, Taylor AM, Bonhoeffer P. Pre-stenting with a bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart. 2011;97:118–23.

    Article  PubMed  Google Scholar 

  36. Uebing A, Rigby ML. The problem of infective endocarditis after transcatheter pulmonary valve implantation. Heart. 2015;10:749–51.

    Article  Google Scholar 

  37. Chen CR, Cheng TO, Huang T, Zhou YL, Chen JY, Huang YG, Li HJ. Percutaneous balloon valvuloplasty for pulmonic stenosis in adolescents and adults. N Engl J Med. 1996;335:21–5.

    Article  CAS  PubMed  Google Scholar 

  38. Zampi JD, Loccoh E, Armstrong AK, Yu S, Lowery R, Rocchini AP, Hirsch-Romano JC. Twenty years of experience with intraoperative pulmonary artery stenting. Catheter Cardiovasc Interv. 2017;90:398–406.

    Article  PubMed  Google Scholar 

  39. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ, Mayo Clinic Congenital Heart Center. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg. 2008;135:1120–36. 1136–7

    Article  PubMed  Google Scholar 

  40. Danielson GK, Maloney JD, Devloo RA. Surgical repair of Ebstein’s anomaly. Mayo Clin Proc. 1979;54:185–92.

    PubMed  CAS  Google Scholar 

  41. Carpentier A, Chauvaud S, Macé L, Relland J, Mihaileanu S, Marino JP, Abry B, Guibourt P. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96:92–101.

    PubMed  CAS  Google Scholar 

  42. da Silva JP, Baumgratz JF, da Fonseca L, Franchi SM, Lopes LM, Tavares GMP, Soares AM, Moreira LF, Barbero-Marcial M. The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215–23.

    Article  PubMed  Google Scholar 

  43. Dearani JA, Mora BN, Nelson TJ, Haile DT, O’Leary PW. Ebstein anomaly review: what’s now, what’s next? Expert Rev Cardiovasc Ther. 2015;13:1101–9.

    Article  CAS  PubMed  Google Scholar 

  44. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ. Functional status after operation for Ebstein anomaly: the Mayo Clinic experience. J Am Coll Cardiol. 2008;52:460–6.

    Article  PubMed  Google Scholar 

  45. Roberts PA, Boudjemline Y, Cheatham JP, Eicken A, Ewert P, McElhinney DB, Hill SL, Berger F, Khan D, Schranz D, Hess J, Ezekowitz MD, Celermajer D, Zahn E. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol. 2011;58:118–22.

    Google Scholar 

  46. Karonis T, Scognamiglio G, Babu-Narayan SV, Montanaro C, Uebing A, Diller GP, Alonso-Gonzalez R, Swan L, Dimopoulos K, Gatzoulis MA, Li W. Clinical course and potential complications of small ventricular septal defects in adulthood: Late development of left ventricular dysfunction justifies lifelong care. Int J Cardiol. 2016;208:102–6.

    Article  PubMed  Google Scholar 

  47. Carminati M, Butera G, Chessa M, Giovanni J De, Fisher G, Gewillig M, Peuster M, Piechaud JF, Santoro G, Sievert H, Spadoni I, Walsh K, Investigators of the European VSD Registry A, Lillehei C, Cohen M, Warden H, Varco R, Kouchoukos N, Blackstone E, Doty D, Hanley F, Karp R, Ross-Hesselink J, Mejiboom F, Spitaels S, Domberg R Van, Rijen E Van, Utens E, Bogers A, Simons M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007;28:2361–8.

    Google Scholar 

  48. Liddy S, Oslizlok P, Walsh KP. Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices. Catheter Cardiovasc Interv. 2013;82:253–9.

    Article  PubMed  Google Scholar 

  49. Campbell M. Natural history of coarctation of the aorta. Br Heart J. 1970;32:633–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Torok RD, Campbell MJ, Fleming GA, Hill KD. Coarctation of the aorta: Management from infancy to adulthood. World J Cardiol. 2015;7:765–75.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Massey R, Shore DF. Surgery for complex coarctation of the aorta. Int J Cardiol. 2004;97:67–73.

    Article  PubMed  Google Scholar 

  52. Forbes TJ, Kim DW, Du W, Turner DR, Holzer R, Amin Z, Hijazi Z, Ghasemi A, Rome JJ, Nykanen D, Zahn E, Cowley C, Hoyer M, Waight D, Gruenstein D, Javois A, Foerster S, Kreutzer J, Sullivan N, Khan A, Owada C, Hagler D, Lim S, Canter J, Zellers T, CCISC Investigators. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol. 2011;58:2664–74.

    Article  Google Scholar 

  53. Forbes TJ, Garekar S, Amin Z, Zahn EM, Nykanen D, Moore P, Qureshi SA, Cheatham JP, Ebeid MR, Hijazi ZM, Sandhu S, Hagler DJ, Sievert H, Fagan TE, Ringewald J, Du W, Tang L, Wax DF, Rhodes J, Johnston TA, Jones TK, Turner DR, CAC P, Hellenbrand WE, Congenital Cardiovascular Interventional Study Consortium (CCISC). Procedural results and acute complications in stenting native and recurrent coarctation of the aorta in patients over 4 years of age: a multi-institutional study. Catheter Cardiovasc Interv. 2007;70:276–85.

    Article  PubMed  Google Scholar 

  54. Fawzy ME, Sivanandam V, Pieters F, Stefadouros MA, Galal O, Dunn B, Kinsara A, Khan B, Al-Halees Z. Long-term effects of balloon angioplasty on systemic hypertension in adolescent and adult patients with coarctation of the aorta. Eur Heart J. 1999;20:827–32.

    Article  CAS  PubMed  Google Scholar 

  55. Lam Y-Y, Kaya MG, Li W, Mahadevan VS, Khan AA, Henein MY, Mullen M. Effect of endovascular stenting of aortic coarctation on biventricular function in adults. Heart. 2007;93:1441–7.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Hassan W, Awad M, Fawzy ME, Al OA, Malik S, Akhras N, Shoukri M. Long-term effects of balloon angioplasty on left ventricular hypertrophy in adolescent and adult patients with native coarctation of the aorta. Up to 18 years follow-up results. Catheter Cardiovasc Interv. 2007;70:881–6.

    Article  PubMed  Google Scholar 

  57. Diller G-P, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, Babu-Narayan S, Wort SJ, Dimopoulos K, Gatzoulis MA. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132:2118–25.

    Article  PubMed  Google Scholar 

  58. Kreutzer J, Graziano JN, Stapleton G, Rome JJ. Late catheter interventions in hypoplastic left heart syndrome. Cardiol Young. 2011;21(Suppl 2):65–76.

    Article  PubMed  Google Scholar 

  59. Hansen JH, Runge U, Uebing A, Scheewe J, Kramer H-H, Fischer G. Cardiac catheterization and interventional procedures as part of staged surgical palliation for hypoplastic left heart syndrome. Congenit Heart Dis. 2012;7:565–74.

    Article  PubMed  Google Scholar 

  60. Sagic D, Otasevic P, Sievert H, Elsasser A, Mitrovic V, Gradinac S. Percutaneous implantation of the left ventricular partitioning device for chronic heart failure: a pilot study with 1-year follow-up. Eur J Heart Fail. 2010;12:600–6.

    Article  PubMed  Google Scholar 

  61. Søndergaard L, Reddy V, Kaye D, Malek F, Walton A, Mates M, Franzen O, Neuzil P, Ihlemann N, Gustafsson F. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure. Eur J Heart Fail. 2014;16:796–801.

    Article  PubMed  Google Scholar 

  62. Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F, Malek F, Van der HJ, Lang I, Petrie MC, Cleland JGF, Leon M, Kaye DM. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet. 2016;387:1298–304.

    Article  PubMed  Google Scholar 

  63. Tutarel O, Kempny A, Alonso-Gonzalez R, Jabbour R, Li W, Uebing A, Dimopoulos K, Swan L, Gatzoulis MA, Diller GP. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35:725–32.

    Article  PubMed  Google Scholar 

  64. Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmaier A, Fam N, Frerker C, Hausleiter J, Juliard J-M, Kaple R, Kreidel F, Kuck KH, Kuwata S, Ancona M, Malasa M, Nazif T, Nickenig G, Nietlispach F, Pozzoli A, Schäfer U, Schofer J, Schueler R, Tang G, Vahanian A, et al. The International Multicenter TriValve Registry: which patients are undergoing transcatheter tricuspid repair? JACC Cardiovasc Interv. 2017;10:1982–90.

    Article  PubMed  Google Scholar 

  65. Franzen O, von Samson P, Dodge-Khatami A, Geffert G, Baldus S. Percutaneous edge-to-edge repair of tricuspid regurgitation in congenitally corrected transposition of the great arteries. Congenit Heart Dis. 2011;6:57–9.

    Article  PubMed  Google Scholar 

  66. Stephan von Bardeleben R, Tamm A, Emrich T, Münzel T, Schulz E. Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband. Eur Heart J. 2017;38:690.

    Article  PubMed  Google Scholar 

  67. Duncan A, Daqa A, Yeh J, Davies S, Uebing A, Quarto C, Moat N. Transcatheter mitral valve replacement: long-term outcomes of first-in-man experience with an apically tethered device—a case series from a single centre. EuroIntervention. 2017;13:e1047–57.

    Article  PubMed  Google Scholar 

  68. Lauten A, Laube A, Schubert H, Bischoff S, Nietzsche S, Horstkötter K, Poudel-Bochmann B, Franz M, Lichtenberg A, Figulla HR, Akhyari P. Transcatheter treatment of tricuspid regurgitation by caval valve implantation—experimental evaluation of decellularized tissue valves in central venous position. Catheter Cardiovasc Interv. 2015;85:150–60.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatric Cardiology, University Hospital Münster, Münster, Germany

    Anselm Uebing

Authors
  1. Anselm Uebing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anselm Uebing .

Editor information

Editors and Affiliations

  1. Royal Brompton Hospital, London, United Kingdom

    Lorna Swan

  2. ATTIKON University Hospital, Athens University, Athens, Greece

    Alexandra A. Frogoudaki

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Uebing, A. (2018). Role of Intervention and Surgery. In: Swan, L., Frogoudaki, A. (eds) Heart Failure in Adult Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-77803-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-77803-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-77802-0

  • Online ISBN: 978-3-319-77803-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation